Professor Alicia Jenkins

Professor
NHMRC Clinical Trials Centre, Sydney Medical School

Telephone 02 95625000
Fax 95621863

Map

Selected grants

2017

  • Biomarkers, Related Mechanisms and Technology to Improve Diabetes Outcomes; Jenkins A; National Health and Medical Research Council (NHMRC)/Career Awards: Practitioner Fellowships.

2016

  • CONCEPT A - The (Fenofibrate and Microvascular Events) FAME 1 Eye Study – Preventing Vision Loss in T1 Diabetes; Jenkins A, Hardikar A, Keech A; Juvenile Diabetes Research Foundation (Australia)/Australian Type 1 Diabetes Clinical Research Network: Centres and Concept Proposals.
  • A novel redox biomarker reflecting oxidative inhibition of a key membrane protein to predict heart failure events; Figtree G, Campbell D, Jenkins A; National Heart Foundation of Australia/Vanguard Grant.
  • Biomarkers for Risk and Outcomes of Type 2 Diabetes: A Discovery and Validation Approach in Australian and Chinese subjects; Keech A, Jenkins A, Sullivan D, Hardikar A, Ma R, Jia W, Wang Y, Li H; National Health and Medical Research Council (NHMRC)/National Natural Science Foundation of China (NSFC).

2015

  • Diabetic Retinopathy - Closing the Loop for Diabetic Eye Care and Complication Risk Mitigation; Keech A, Jenkins A, Henderson T, Brown A, Bursell S, Brazionis L, Craig J, Maple-Brown L, O'Dea K, Gebski V; National Health and Medical Research Council (NHMRC)/Centres for Research Excellence.
  • ORS glucose sensors in Type 1 diabetes; O'Neal D, Jenkins A; St Vincents Hospital Melbourne/Research Grant.
  • An international collaboration to improve diabetes outcomes; Jenkins A; Sydney Medical School Foundation/Foundation Grant.
  • A Global Approach to Understanding and Improving Diabetes Heart Health; Jenkins A; University of Sydney/Sydney Medical School Foundation Grant.
  • Insulin kinetics in exercise in CSII using Type 1 diabetes adults; McAuley S, Jenkins A; St Vincents Hospital Melbourne/Research Grant.
  • JDRF Australia Closing the Loop Overnight in Home; Jenkins A, O'Neal D; Juvenile Diabetes Research Foundation International (JDRF)/Research Grant.

2014

  • FAME 1 - Eye; Jenkins A, Donaghue K, O'Neal D, Best J; National Health and Medical Research Council (NHMRC)/Project Grants.
  • The role of residual beta-cell function on the risk of diabetes complications in children, adolescents and adults with type 1 diabetes; Cho Y, Donaghue K, Januszewski A, Jenkins A, Craig M, Benitez-Aguirre P; Diabetes Australia Research Trust (DART)/Diabetes Research Grant Program.
  • Purchase of the Retina Tomograph Platform with Corneal Confocal Microscope module; Keech A, Jenkins A; National Health and Medical Research Council (NHMRC)/Equipment Grants.
  • Closed Loop Insulin Pumps in the Home; Jenkins A, O'Neal D; Juvenile Diabetes Research Foundation International (JDRF)/Research Grant.
  • The protective effects of fenofibrate in diabetes-related susceptibility to ischaemia; Ng M, Jenkins A; National Health and Medical Research Council (NHMRC)/Project Grants.

2013

  • FIELD LIFE: Epigenetics of Type 2 diabetes complications; Keech A, Jenkins A; National Health and Medical Research Council (NHMRC)/Project Grants.
  • Glycaemia in ICU patients; Jenkins A, Deane A; Diabetes Australia Research Trust (DART)/Research Grants.
  • Insulin pumps and basal rate change pharmacokinetics; Jenkins A, McAuley S; Australian Diabetes Society/Research Support.
  • Predicting response to fenofibrate (using NMR lipidomics) in the FIELD study; Miekle P, Jenkins A; National Health and Medical Research Council (NHMRC)/Project Grants.
  • Diabetic Retinopathy Assessment - Low cost cameras with L Brazionis; Jenkins A; Australian Diabetes Society/Research Support.

2012

  • Vascular Risk Factors in CSII vs. MDI treated Type 1 diabetic patients; Jenkins A; St Vincent's Clinic Foundation/Multidisciplinary Grants.
  • PEDF and NMR determined lipoproteins in Type 1 and Type 2 diabetes; Jenkins A, Lyons T; American Diabetes Association/Research Support.
  • Insulin levels in Type 1 diabetes patients; Jenkins A; St Vincents Hospital Melbourne/Research Endowment Fund.
  • Testosterone intervention for the prevention of diabetes mellitus in high risk men: a randomised trial; Jenkins A, Wittert G; National Health and Medical Research Council (NHMRC)/Project Grants.
  • TEAMSNET Telemedicine for Diabetes Eye Care; Bursell S, Jenkins A; Fred Hollows Foundation/Research Support.
  • Testosterone for the Prevention of Type 2 Diabetes; Jenkins A, Wittert G; National Health and Medical Research Council (NHMRC)/Research Support.
  • C-Peptide levels in Type 1 diabetes patients; Jenkins A; St Vincent's Clinic Foundation/Multidisciplinary Grants.

2011

  • Telehealth Facilitation of Diabetes and Cardiovascular Care in Australia; Bursell S, Jenkins A; National Health and Medical Research Council (NHMRC)/Partnership Projects.
  • Psychosocial aspects of Type 1 diabetes care and motherhood; Jenkins A, Rasmussen B; Novo Nordisk Pharmaceuticals Pty Ltd/Research Grant.
  • REMOVAL sub-study: Reducing with Metformin Vascular Adverse Lesions in type 1 diabetes; Jenkins A; Juvenile Diabetes Research Foundation International (JDRF)/Research Grant.
  • REMOVAL study: Reducing with Metformin Vascular Adverse Lesions in type 1 diabetes; Jenkins A, Petrie J; Juvenile Diabetes Research Foundation International (JDRF)/Research Grant.
  • Telemedicine for Diabetes and Cardiovascular Disease Care; Jenkins A, Bursell S; National Health and Medical Research Council (NHMRC)/Partnership Projects.

2010

  • FIELD Study: Unlocking the genetics of diabetes complications; Jenkins A, Keech A; National Health and Medical Research Council (NHMRC)/Project Grants.
  • Vascular Risk Factors in CSII vs. MDI treated Type 1 diabetic patients; Jenkins A; St Vincent's Clinic Foundation/Multidisciplinary Grants.
  • Transition to Motherhood for Women with Type 1 diabetes; Rasmussen B, Jenkins A; Deakin University/Project Grant.
  • Florey Adelaide Male Ageing Study (FAMAS); Wittert G, Jenkins A; National Health and Medical Research Council (NHMRC)/Project Grants.
  • General Practice based Insulin Commencement in Type 2 diabetes with Continuous Glucose Monitoring Support; Jenkins A, O'Neal D; Sanofi Medtronic Diabetes Global Alliance/Investigator Sponsored Study.
  • Psychosocial aspects of Type 1 diabetes care and motherhood; Jenkins A, Rasmussen B; Deakin University/Project Grant.

2009

  • Retinal Vascular Health and Diabetes Complications; Jenkins A, Keech A; National Heart Foundation/Research Grant.
  • Telemedicine; Jenkins A; The University of Melbourne/Knowledge Transfer Grant.
  • Lipoproteins and PEDF in the Vascular Complications of Diabetes; Lyons T, Jenkins A; National Institutes of Health/Research Grants.
  • Telemedicine; Jenkins A; University of Hawaii/Research Grant.

Selected publications

Download citations: PDF RTF Endnote

Books

  • Jenkins, A., Breen, R., Lindsay, R., Brew, A. (2003). Reshaping Teaching In Higher Education: Linking Teaching With Research. UK: RoutledgeFalmer imprint of Taylor & Francis.

Journals

  • Kaidonis, G., Gillies, M., Abhary, S., Liu, E., Essex, R., Chang, J., Pal, B., Sivaprasad, S., Pefkianaki, M., Daniell, M., et al (2016). A single-nucleotide polymorphism in the MicroRNA-146a gene is associated with diabetic nephropathy and sight-threatening diabetic retinopathy in Caucasian patients. Acta Diabetologica, 53(4), 643-650. [More Information]
  • Zhang, Y., Jenkins, A., Basu, A., Stoner, J., Lopes-Virella, M., Klein, R., Lyons, T. (2016). Associations between intensive diabetes therapy and NMR-determined lipoprotein subclass profiles in Type 1 diabetes. Journal of Lipid Research, 57(2), 310-317. [More Information]
  • Joglekar, M., Januszewski, A., Jenkins, A., Hardikar, A. (2016). Circulating microRNA Biomarkers of Diabetic Retinopathy. Diabetes, 65(1), 22-24. [More Information]
  • Ritte, R., Luke, J., Nelson, C., Brown, A., O'Dea, K., Jenkins, A., Best, J., McDermott, R., Daniel, M., Rowley, K. (2016). Clinical outcomes associated with albuminuria in central Australia: a cohort study. BMC Nephrology, 17(1). [More Information]
  • Basu, A., Jenkins, A., Zhang, Y., Stoner, J., Klein, R., Lopes-Virella, M., Garvey, W., Lyons, T. (2016). Data on carotid intima-media thickness and lipoprotein subclasses in type 1 diabetes from the Diabetes Control and Complications Trial and the Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC). Data in Brief, 6, 33-38. [More Information]
  • Tully, P., Baumeister, H., Martin, S., Atlantis, E., Jenkins, A., Januszewski, A., O'Loughlin, P., Taylor, A., Wittert, G. (2016). Elucidating the Biological Mechanisms Linking Depressive Symptoms With Type 2 Diabetes in Men: The Longitudinal Effects of Inflammation, Microvascular Dysfunction, and Testosterone. Psychosomatic Medicine, 78(2), 221-232. [More Information]
  • Bursell, S., Zang, S., Keech, A., Jenkins, A. (2016). Evolving telehealth reimbursement in Australia. Internal Medicine Journal, 46(8), 977-981. [More Information]
  • McAuley, S., Dang, T., Horsburgh, J., Bansal, A., Ward, G., Aroyan, S., Jenkins, A., MacIsaac, R., Shah, R., O'Neal, D. (2016). Feasibility of an Orthogonal Redundant Sensor incorporating Optical plus Redundant Electrochemical Glucose Sensing. Journal of Diabetes Science and Technology, 10(3), 679-688. [More Information]
  • Ogle, G., Kim, H., Middlehurst, A., Silink, M., Jenkins, A. (2016). Financial costs for families of children with Type 1 diabetes in lower-income countries. Diabetic Medicine, 33(6), 820-826. [More Information]
  • Joglekar, M., Trivedi, P., Kay, T., Hawthorne, W., O'Connell, P., Jenkins, A., Hardikar, A., Thomas, H. (2016). Human islet cells are killed by BID-independent mechanisms in response to FAS ligand. Apoptosis, 21(4), 379-389. [More Information]
  • Manski-Nankervis, J., Yates, C., Blackberry, I., Furler, J., Ginnivan, L., Cohen, N., Jenkins, A., Vasanthakumar, S., Gorelik, A., Young, D., et al (2016). Impact of insulin initiation on glycaemic variability and glucose profiles in a primary healthcare Type 2 diabetes cohort: Analysis of continuous glucose monitoring data from the INITIATION study. Diabetic Medicine, 33(6), 803-811. [More Information]
  • McAuley, S., Horsburgh, J., Ward, G., La Gerche, A., Gooley, J., Jenkins, A., MacIsaac, R., O'Neal, D. (2016). Insulin pump basal adjustment for exercise in type 1 diabetes: a randomised crossover study. Diabetologia, 59(8), 1636-1644. [More Information]
  • Kar, P., Plummer, M., Bellomo, R., Jenkins, A., Januszewski, A., Chapman, M., Jones, K., Horowitz, M., Deane, A. (2016). Liberal Glycemic Control in Critically Ill Patients with Type 2 Diabetes: An Exploratory Study. Critical Care Medicine, 44(9), 1695-1703. [More Information]
  • Williams, K., Sullivan, D., Veillard, A., O'Brien, R., George, J., Jenkins, A., Young, S., Ehnholm, C., Duffield, A., Twigg, S., Keech, A. (2016). Low alanine aminotransferase levels and higher number of cardiovascular events in people with Type 2 diabetes: analysis of the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study. Diabetic Medicine, 33(3), 356-364. [More Information]
  • Li, J., Wittert, G., Vincent, A., Atlantis, E., Shi, Z., Appleton, S., Hill, C., Jenkins, A., Januszewski, A., Adams, R. (2016). Muscle grip strength predicts incident type 2 diabetes: Population-based cohort study. Metabolism: Clinical and Experimental, 65(6), 883-892. [More Information]
  • Basu, A., Jenkins, A., Zhang, Y., Stoner, J., Klein, R., Lopes-Virella, M., Garvey, W., Lyons, T., Research Group, T. (2016). Nuclear magnetic resonance-determined lipoprotein subclasses and carotid intima-media thickness in type 1 diabetes. Atherosclerosis, 244, 93-100. [More Information]
  • Luke, J., Schmidt, D., Ritte, R., O'Dea, K., Brown, A., Piers, L., Jenkins, A., Rowley, K. (2016). Nutritional predictors of chronic disease in a Central Australian Aboriginal cohort: A multi-mixture modelling analysis. Nutrition, Metabolism & Cardiovascular Diseases, 26(2), 162-168. [More Information]
  • Luke, J., Ritte, R., O'Dea, K., Brown, A., Piers, L., Jenkins, A., Rowley, K. (2016). Nutritional predictors of successful chronic disease prevention for a community cohort in Central Australia. Public Health Nutrition, 19(13), 2475-2483. [More Information]
  • Williams, K., Sullivan, D., Nicholson, G., George, J., Jenkins, A., Januszewski, A., Gebski, V., Manning, P., Tan, Y., Donoghoe, M., Buizen, L., Twigg, S., Keech, A., et al (2016). Opposite associations between alanine aminotransferase and γ-glutamyl transferase levels and all-cause mortality in type 2 diabetes: Analysis of the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study. Metabolism: Clinical and Experimental, 65(5), 783-793. [More Information]
  • Stern, K., Cho, Y., Benitez-Aguirre, P., Jenkins, A., McGill, M., Mitchell, P., Keech, A., Donaghue, K. (2016). QT interval, corrected for heart rate, is associated with HbA1c concentration and autonomic function in diabetes. Diabetic Medicine, 33(10), 1415-1421. [More Information]
  • Sharifi, A., Varsavsky, A., Ulloa, J., Horsburgh, J., McAuley, S., Krishnamurthy, B., Jenkins, A., Colman, P., Ward, G., MacIsaac, R., et al (2016). Redundancy in Glucose Sensing: Enhanced Accuracy and Reliability of an Electrochemical Redundant Sensor for Continuous Glucose Monitoring. Journal of Diabetes Science and Technology, 10(3), 669-678. [More Information]
  • Noonan, J., Ward, G., Sarossy, M., Man, R., Nguyen, T., Jenkins, A., Dusting, G., Lamoureux, J. (2016). Retinal neuronal and vascular function in type 1 diabetes adults during glycaemic clamps. Clinical and Experimental Pharmacology and Physiology, 43(3), 382-384. [More Information]
  • Januszewski, A., Sutanto, S., McLennan, S., O'Neal, D., Keech, A., Twigg, S., Jenkins, A. (2016). Shorter telomeres in adults with Type 1 diabetes correlate with diabetes duration, but only weakly with vascular function and risk factors. American Journal Of Hematology, 117, 4-11. [More Information]
  • O'Brien, C., Ski, C., Thompson, D., Moore, G., Mancuso, S., Jenkins, A., Ward, G., MacIsaac, R., Loh, M., et al (2016). The Mental Health in Diabetes Service (MINDS) to enhance psychosocial health: study protocol for a randomized controlled trial. Trials, 17(1), 1-10. [More Information]
  • Stitt, A., Curtis, T., Chen, M., Medina, R., McKay, G., Jenkins, A., Gardiner, T., Lyons, T., Hammes, H., Simo, R., et al (2016). The progress in understanding and treatment of diabetic retinopathy. Progress in Retinal and Eye Research, 51, 156-186. [More Information]
  • Traill, C., Januszewski, A., Larkins, R., Keech, A., Jenkins, A. (2016). Time to research Australian female physician-researchers. Internal Medicine Journal, 46(4), 412-419. [More Information]
  • Traill, C., Januszewski, A., Larkins, R., Keech, A., Jenkins, A. (2016). Time to research Australian physician-researchers. Internal Medicine Journal, 46(5), 550-558. [More Information]
  • Hookham, M., Yu, J., Jenkins, A., Hanssen, K., Aston, C., Lyons, T. (2015). [146-POS]: Levels of urinary NGAL and KIM-1 early in pregnancy are indicative of subclinical kidney injury in diabetic women who subsequently developed pre-eclampsia. Pregnancy Hypertension: an international journal of women's cardiovascular health, 5(1), 75-76. [More Information]
  • Farr, R., Januszewski, A., Joglekar, M., Liang, H., McAulley, A., Hewitt, A., Thomas, H., Loudovaris, T., Kay, T., Jenkins, A., Hardikar, A. (2015). A comparative analysis of high-throughput platforms for validation of a circulating microRNA signature in diabetic retinopathy. Scientific Reports, 5, 1-13. [More Information]
  • Ho, M., Benitez-Aguirre, P., Donaghue, K., Mitchell, P., Baur, L., Jenkins, A., Craig, M., Cowell, C., Garnett, S. (2015). Arterial elasticity in obese adolescents with clinical features of insulin resistance. Diabetes and Vascular Disease Research, 12(1), 62-69. [More Information]
  • Jenkins, A., Joglekar, M., Hardikar, A., Keech, A., O'Neal, D., Januszewski, A. (2015). Biomarkers in Diabetic Retinopathy. The Review of Diabetic Studies, 12(1-2), 159-195. [More Information]
  • Sasongko, M., Wong, T., Jenkins, A., Nguyen, T., Shaw, J., Wang, J. (2015). Circulating markers of inflammation and endothelial function, and their relationship to diabetic retinopathy. Diabetic Medicine, 32(5), 686-691. [More Information]
  • Kaidonis, G., Burdon, K., Gillies, M., Abhary, S., Essex, R., Chang, J., Pal, B., Pefkianaki, M., Daniell, M., Lake, S., Jenkins, A., et al (2015). Common Sequence Variation in the VEGFC Gene Is Associated with Diabetic Retinopathy and Diabetic Macular Edema. Ophthalmology, 122(9), 1828-1836. [More Information]
  • Pipingas, A., Sinclair, A., Croft, K., Januszewski, A., Jenkins, A., Mori, T., Cockerell, R., Grima, N., Stough, C., Scholey, A., et al (2015). Fish oil and multivitamin supplementation reduces oxidative stress but not inflammation in healthy older adults: A randomised controlled trial. Journal of Functional Foods, 19, 949-957. [More Information]
  • Burdon, K., Fogarty, R., Shen, W., Abhary, S., Kaidonis, G., Appukuttan, B., Hewitt, A., Sharma, S., Daniell, M., Essex, R., Jenkins, A., Gillies, M., et al (2015). Genome-wide association study for sight-threatening diabetic retinopathy reveals association with genetic variation near the GRB2 gene. Diabetologia, 58(10), 2288-2297. [More Information]
  • Xu, S., Alexander, K., Bryant, W., Cohen, N., Craig, M., Forbes, M., Fulcher, G., Greenaway, T., Harrison, N., Holmes-Walker, J., Jenkins, A., et al (2015). Healthcare professional requirements for the care of adult diabetes patients managed with insulin pumps in Australia. Internal Medicine Journal, 45(1), 86-93. [More Information]
  • Chin, J., Fulcher, J., Jenkins, A., Keech, A. (2015). Is it Time to Repair a Fairly Fast SAAB Convertible? Testing an Evidence-based Mnemonic for the Secondary Prevention of Cardiovascular Disease. Heart, Lung and Circulation, 24(5), 480-487. [More Information]
  • Martin, S., Vincent, A., Taylor, A., Atlantis, E., Jenkins, A., Januszewski, A., O'Loughlin, P., Wittert, G. (2015). Lower Urinary Tract Symptoms, Depression, Anxiety and Systemic Inflammatory Factors in Men: A Population-Based Cohort Study. PloS One, 10(10), 1-18. [More Information]
  • Sabeti, F., Nolan, C., James, A., Jenkins, A., Maddess, T. (2015). Multifocal Pupillography Identifies Changes in Visual Sensitivity According to Severity of Diabetic Retinopathy in Type 2 Diabetes. Investigative Ophthalmology & Visual Science, 56(8), 4504-4513. [More Information]
  • Hardikar, A., Satoor, S., Karandikar, M., Joglekar, M., Puranik, A., Wong, W., Kumar, S., Limaye, A., Bhat, D., Januszewski, A., Keech, A., Jenkins, A., et al (2015). Multigenerational Undernutrition Increases Susceptibility to Obesity and Diabetes that Is Not Reversed after Dietary Recuperation. Cell Metabolism, 22(2), 312-319. [More Information]
  • Ong, K., Januszewski, A., O'Connell, R., Buizen, L., Jenkins, A., Xu, A., Sullivan, D., Barter, P., Scott, R., Taskinen, M., Rye, K., Keech, A. (2015). Relationship of fibroblast growth factor 21 with baseline and new on-study microvascular disease in the Fenofibrate Intervention and Event Lowering in Diabetes study. Diabetologia, 59(8), 2035-2044. [More Information]
  • Herrmann, M., Sullivan, D., Veillard, A., McCorquodale, T., Straub, I., Scott, R., Laakso, M., Topliss, D., Jenkins, A., Blankenberg, S., Keech, A., et al (2015). Serum 25-Hydroxy Vitamin D: A Predictor of Macrovascular and Microvascular Complications in Patients With Type 2 Diabetes. Diabetes Care, 38(3), 521-528. [More Information]
  • Benitez-Aguirre, P., Craig, M., Cass, H., Sugden, C., Jenkins, A., Wang, J., Cusumano, J., Hodgson, L., Lee, K., Wong, T., Donaghue, K. (2015). Sex differences in retinal microvasculature through puberty in type 1 diabetes: are girls at greater risk of diabetic microvascular complications? Investigative Ophthalmology & Visual Science, 56(1), 571-577. [More Information]
  • Tully, P., Baumeister, H., Bengel, J., Jenkins, A., Januszewski, A., Martin, S., Wittert, G. (2015). The longitudinal association between inflammation and incident depressive symptoms in men: The effects of hs-CRP are independent of abdominal obesity and metabolic disturbances. Physiology and Behavior, 139, 328-335. [More Information]
  • Ong, K., Januszewski, A., O'Connell, R., Jenkins, A., Xu, A., Sullivan, D., Barter, P., Hung, W., Scott, R., Taskinen, M., Keech, A., Rye, K. (2015). The relationship of fibroblast growth factor 21 with cardiovascular outcome events in the Fenofibrate Intervention and Event Lowering in Diabetes study. Diabetologia, 58(3), 464-473. [More Information]
  • Jenkins, A. (2015). The world I want - A world with less diabetes. Medical Journal of Australia, 202(2), 108-109. [More Information]
  • Basu, A., Yu, J., Jenkins, A., Nankervis, A., Hanssen, K., Henriksen, T., Lorentzen, B., Garg, S., Menard, K., Hammad, S., et al (2015). Trace elements as predictors of preeclampsia in type 1 diabetic pregnancy. Nutrition Research, 35(5), 421-430. [More Information]
  • Jenkins, A., Fu, D., Azar, M., Stoner, J., Kaufman, D., Zhang, S., Klein, R., Lopes-Virella, M., Ma, J., Lyons, T. (2014). Clinical correlates of serum pigment epithelium-derived factor in type 2 diabetes patients. Journal of Diabetes and Its Complications, 28, 353-359. [More Information]
  • McBride, J., Jenkins, A., Liu, X., Zhang, B., Lee, K., Berry, W., Janknecht, R., Griffin, C., Aston, C., Lyons, T., et al (2014). Elevated Circulation Levels of an Antiangiogenic SERPIN in Patients with Diabetic Microvascular Complications Impair Wound Healing through Suppression of Wnt Signaling. Journal of Investigative Dermatology, 134, 1725-1734. [More Information]
  • Noonan, J., Dusting, G., Nguyen, T., Jenkins, A., Man, R., Best, W., Dias, D., Jayasinghe, N., Roessner, U., Lamoureux, E. (2014). Flicker Light-Induced Retinal Vasodilation is Unaffected by Inhibition of Epoxyeicosatrienoic Acids and Prostaglandins in Humans. Investigative Ophthalmology & Visual Science, 55(10), 7007-7013. [More Information]
  • Waldman, B., Jenkins, A., Davis, T., Taskinen, M., Scott, R., O'Connell, R., Gebski, V., Ng, M., Keech, A. (2014). HDL-C and HDL-C/ApoA-I Predict Long-Term Progression of Glycemia in Established Type 2 Diabetes. Diabetes Care, 37(8), 2351-2358. [More Information]
  • Ding, L., Cheng, R., Hu, Y., Takahashi, Y., Jenkins, A., Keech, A., Humphries, K., Gu, X., Elliott, M., Xia, X., et al (2014). Peroxisome Proliferator–Activated Receptor α Protects Capillary Pericytes in the Retina. The American Journal of Pathology, 184(10), 2709-2720. [More Information]
  • Januszewski, A., Mason, N., Karschimkus, C., Rowley, K., Best, J., O'Neal, D., Jenkins, A. (2014). Plasma semicarbazide-sensitive amine oxidase activity in type 1 diabetes is related to vascular and renal function but not to glycaemia. Diabetes and Vascular Disease Research, 11(4), 262-269. [More Information]
  • Basu, A., Jenkins, A., Stoner, J., Thorpe, S., Klein, R., Lopes-Virella, M., Garvey, W., Lyons, T. (2014). Plasma total homocysteine and carotid intima-media thickness in type 1 diabetes: A prospective study. Atherosclerosis, 236(1), 188-195. [More Information]
  • Hendrieckx, C., Halliday, J., Bowden, J., Colman, P., Cohen, N., Jenkins, A., Speight, J. (2014). Severe hypoglycaemia and its association with psychological well-being in Australian adults with type 1 diabetes attending specialist tertiary clinics. Diabetes Research and Clinical Practice, 103(3), 430-436. [More Information]
  • Jenkins, A. (2014). Sometimes you have to give a man a fish. Medical Journal of Australia, 200(2), 122-123. [More Information]
  • Vethakkan, S., Walters, J., Gooley, J., Boston, R., Kay, T., Goodman, D., Jenkins, A., Ward, G. (2014). The incretin response after successful islet transplantation. Transplantation, 97(2), e9-e11. [More Information]
  • Naser, N., Januszewski, A., Brown, B., Jenkins, A., Hill, M., Murphy, T. (2013). Advanced glycation end products acutely impair ca(2+) signaling in bovine aortic endothelial cells. Frontiers in Physiology, 4, 1-14. [More Information]
  • Noonan, J., Jenkins, A., Ma, J., Keech, A., Wang, J., Lamoureux, E. (2013). An Update on the Molecular Actions of Fenofibrate and Its Clinical Effects on Diabetic Retinopathy and Other Microvascular End Points in Patients With Diabetes. Diabetes, 62(12), 3968-3975. [More Information]
  • Brown, B., Nobecourt, E., Zeng, J., Jenkins, A., Rye, K., Davies, M. (2013). Apolipoprotein A-I glycation by Glucose and Reactive Aldehydes Alters Phospholipid Affinity but Not Cholesterol Export from Lipid-Laden Macrophages. PloS One, 8(5), 1-9. [More Information]
  • Azar, M., Lyons, T., Alaupovic, P., Stoner, J., Quiroga, C., Kaufman, D., Lopes-Virella, M., Klein, R., Jenkins, A. (2013). Apolipoprotein-defined and NMR lipoprotein subclasses in the Veterans Affairs Diabetes Trial. Journal of Diabetes and Its Complications, 27(6), 627-632. [More Information]
  • Jenkins, A., Yu, J., Alaupovic, P., Basu, A., Klein, R., Lopes-Virella, M., Baker, N., Hunt, K., Lackland, D., Garvey, W., et al (2013). Apolipoprotein-defined lipoproteins and apolipoproteins: Associations with abnormal albuminuria in type 1 diabetes in the diabetes control and complications trial/epidemiology of diabetes interventions and complications cohort. Journal of Diabetes and Its Complications, 27(5), 447-453. [More Information]
  • Jenkins, A., O'Neal, D. (2013). Dyslipidaemia in diabetes: a common problem worth treating to target. Endocrinology Today: peer reviewed updates for medical practitioners, 2(2), 24-29.
  • O'Neal, D., Adhya, S., Jenkins, A., Ward, G., Welsh, J., Voskanyan, G. (2013). Feasibility of adjacent insulin infusion and continuous glucose monitoring via the Medtronic Combo-Set. Journal of Diabetes Science and Technology, 7(2), 381-388. [More Information]
  • Seller, D., Scibilia, R., Rodda, C., Jenkins, A. (2013). Growth in insulin pump use in Australian children with Type 1 Diabetes, and subsequent impact on a diabetes camp program. Infusystems Asia, 8(3), 25-30.
  • Samaras, K., Viardot, A., Botelho, N., Jenkins, A., Lord, R. (2013). Immune cell-mediated inflammation and the early improvements in glucose metabolism after gastric banding surgery. Diabetologia, 56(12), 2564-2572.
  • Hunt, K., Baker, N., Cleary, P., Backlund, J., Lyons, T., Jenkins, A., Virella, G., Lopes-Virella, M. (2013). Oxidized LDL and AGE-LDL in circulating immune complexes strongly predict progression of carotid artery IMT in type 1 diabetes. Atherosclerosis, 231(2), 315-322. [More Information]
  • Alexander, K., Bryant, W., Cohen, N., Craig, M., Forbes, M., Fulcher, G., Greenaway, T., Harrison, N., Holmes-Walker, J., Howard, G., Jenkins, A., et al (2013). Provision of Quality Care for Adults with Type 1 Diabetes Requiring Insulin Pump Therapy (IIPT). Infusystems Asia, 8(1), 1-6.
  • Rasmussen, B., Hendrieckx, C., Clarke, B., Botti, M., Dunning, T., Jenkins, A., Speight, J. (2013). Psychosocial issues of women with type 1 diabetes transitioning to motherhood: a structured literature review. BMC Pregnancy and Childbirth, 13, 2-10. [More Information]
  • Samaras, K., Viardot, A., Lee, P., Jenkins, A., Botelho, N., Bakopanos, A., Lord, R., Hayward, C. (2013). Reduced arterial stiffness after weight loss in obese type 2 diabetes and impaired glucose tolerance: the role of immune cell activation and insulin resistance. Diabetes and Vascular Disease Research, 10(1), 40-48. [More Information]
  • Campbell, D., Somaratne, J., Jenkins, A., Prior, D., Yii, M., Kenny, J., Newcomb, A., Kelly, D., Black, M. (2013). Reduced microvascular density in non-ischemic myocardium of patients with recent non-ST-segment-elevation myocardial infarction. International Journal of Cardiology, 167(3), 1027-1237. [More Information]
  • Luke, J., Brown, A., Daniel, M., O'Dea, K., Best, J., Jenkins, A., Wang, Z., McDermott, R., Wang, Z., Rowley, K. (2013). Response to the Letter by Kawada et al. regarding the manuscript entitled "The metabolic syndrome and CVD outcomes for a central Australian cohort". Diabetes Research and Clinical Practice, 102(2), e22-e23. [More Information]
  • Du, M., Basu, A., Fu, D., Wu, M., Centola, M., Jenkins, A., Hanssen, K., Garg, S., Hammad, S., Scardo, J., et al (2013). Serum inflammatory markers and preeclampsia in type 1 diabetes: a prospective study. Diabetes Care, 36(7), 2054-2061. [More Information]
  • Bursell, S., Jenkins, A., Brazionisb, L., Rowley, K., Brown, A. (2013). Telehealth in Australia: an evolution in health care services. Medical Journal of Australia, 199(1), 23-24. [More Information]
  • Luke, J., Brown, A., Daniell, M., O'Dea, K., Best, J., Jenkins, A., Wang, Z., McDermott, R., Wang, Z., Rowley, K. (2013). The metabolic syndrome and CVD outcomes for a central Australian cohort. Diabetes Research and Clinical Practice, 100(3), e70-e73. [More Information]
  • Chen, Y., Hu, Y., Lin, M., Jenkins, A., Keech, A., Mott, R., Lyons, T., Ma, J. (2013). Therapeutic Effects of PPARα Agonists on Diabetic Retinopathy in Type 1 Diabetes Models. Diabetes, 62(1), 261-272. [More Information]
  • Jenkins, A., O'Neal, D. (2013). What do insulin pumps offer in diabetes care? Endocrinology Today: peer reviewed updates for medical practitioners, 2(4), 27-30.
  • Ting, R., Keech, A., Drury, P., Donoghoe, M., Hedley, J., Jenkins, A., Davis, T., Lehto, S., Celermajer, D., Simes, R., Rajamani, K., et al (2012). Benefits and Safety of Long-Term Fenofibrate Therapy in People With Type 2 Diabetes and Renal Impairment - The FIELD Study. Diabetes Care, 35(2), 218-225. [More Information]
  • Campbell, D., Somaratne, J., Jenkins, A., Prior, D., Yii, M., Kenny, J., Newcomb, A., Schalkwijk, C., Black, M., Kelly, D. (2012). Diastolic dysfunction of aging is independent of myocardial structure but associated with plasma advanced glycation end-product levels. PloS One, 7(11), 1-14. [More Information]
  • Lopes-Virella, M., Jenkins, A., Baker, N., Virella, G., Hunt, K., Lyons, T., et al (2012). High concentrations of AGE-LDL and oxidized LDL in circulating immune complexes are associated with progression of retinopathy in type 1 diabetes. Diabetes Care, 35(6), 1333-1340. [More Information]
  • Ong, K., Rye, K., O'Connell, R., Jenkins, A., Brown, C., Xu, A., Sullivan, D., Barter, P., Keech, A. (2012). Long-Term Fenofibrate Therapy Increases Fibroblast Growth Factor 21 and Retinol-Binding Protein 4 in Subjects with Type 2 Diabetes. Journal of Clinical Endocrinology and Metabolism, 97(12), 4701-4708. [More Information]
  • Januszewski, A., Sachithanandan, N., Karschimkus, C., o'neal, D., Yeung, C., Alkatib, N., Jenkins, A. (2012). Non-invasive measures of tissue autofluorescence are increased in Type 1 diabetes complications and correlate with a non-invasive measure of vascular dysfunction. Diabetic Medicine, 29(6), 726-733. [More Information]
  • Vethakkan, S., Walters, J., Gooley, J., Boston, R., Kay, T., Goodman, D., Jenkins, A., Ward, G. (2012). Normalized NEFA dynamics during an OGTT after islet transplantation. Transplantation, 94(7), e49-e51. [More Information]
  • Sasongko, M., Wong, T., Nguyen, T., Shaw, J., Jenkins, A., Wang, J. (2012). Novel versus traditional risk markers for diabetic retinopathy. Diabetologia, 55(3), 666-670. [More Information]
  • Benitez-Aguirre, P., Craig, M., Jenkins, A., Gallego, P., Cusumano, J., Duffin, A., Hing, S., Donaghue, K. (2012). Plantar Fascia Thickness is Longitudinally Associated with Retinopathy and Renal Dysfunction: A Prospective Study from Adolescence to Adulthood. Journal of Diabetes Science and Technology, 6(2), 348-355. [More Information]
  • Januszewski, A., Karschimkus, C., Davis, K., O'Neal, D., Ward, G., Jenkins, A. (2012). Plasma 1,5 anhydroglucitol levels, a measure of short-term glycaemia: Assay assessment and lower levels in diabetic vs. non-diabetic subjects. Diabetes Research and Clinical Practice, 95(1), e17-e19. [More Information]
  • Basu, A., Alaupovic, P., Wu, M., Jenkins, A., Yu, Y., Nankervis, A., Hanssen, K., Scholz, H., Henriksen, T., Lorentzen, B., et al (2012). Plasma lipoproteins and preeclampsia in women with type 1 diabetes: a prospective study. Journal of Clinical Endocrinology and Metabolism, 97(5), 1752-1762. [More Information]
  • Sasongko, M., Wong, T., Donaghue, K., Cheung, N., Jenkins, A., Benitez-Aguirre, P., Wang, J. (2012). Retinal Arteriolar Tortuosity is Associated With Retinopathy and Early Kidney Dysfunction in Type 1 Diabetes. American Journal of Ophthalmology, 153(1), 176-183. [More Information]
  • Benitez-Aguirre, P., Sasongko, M., Craig, M., Jenkins, A., Cusumano, J., Cheung, N., Wong, T., Donaghue, K. (2012). Retinal vascular geometry predicts incident renal dysfunction in young people with type 1 diabetes. Diabetes Care, 35(3), 599-604. [More Information]
  • Sasongko, M., Wong, T., Nguyen, T., Kawasaki, R., Jenkins, A., Shaw, J., Robinson, C., Wang, J. (2012). Serum Apolipoproteins are Associated With Systemic and Retinal Microvascular Function in People With Diabetes. Diabetes, 61(7), 1785-1792. [More Information]
  • Bursell, S., Brazionis, L., Jenkins, A. (2012). Telemedicine and ocular health in diabetes mellitus. Clinical & Experimental Optometry, 95(3), 311-327. [More Information]
  • Davis, T., Ting, R., Best, J., Donoghoe, M., Drury, P., Sullivan, D., Jenkins, A., O'Connell, R., Whiting, M., Glasziou, P., Simes, R., Gebski, V., Keech, A., et al (2011). Effects of fenofibrate on renal function in patients with type 2 diabetes mellitus: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) Study. Diabetologia, 54(2), 280-290. [More Information]
  • Tabet, F., Lambert, G., Torres, L., Hou, L., Sotirchos, I., Touyz, R., Jenkins, A., Barter, P., Rye, K. (2011). Lipid-Free Apolipoprotein A-I and Discoidal Reconstituted High-Density Lipoproteins Differentially Inhibit Glucose-Induced Oxidative Stress in Human Macrophages. Arteriosclerosis, Thrombosis, and Vascular Biology, 31(5), 1192-1200. [More Information]
  • Benitez-Aguirre, P., Craig, M., Sasongko, M., Jenkins, A., Wong, T., Wang, J., Cheung, N., Donaghue, K. (2011). Retinal Vascular Geometry Predicts Incident Retinopathy in Young People With Type 1 Diabetes. Diabetes Care, 34(7), 1622-1627. [More Information]
  • Sasongko, M., Wong, T., Nguyen, T., Kawasaki, R., Jenkins, A., Shaw, J., Wang, J. (2011). Serum Apolipoprotein AI and B Are Stronger Biomarkers of Diabetic Retinopathy Than Traditional Lipids. Diabetes Care, 34(2), 474-479. [More Information]
  • Sasongko, M., Wang, J., Donaghue, K., Cheung, N., Benitez-Aguirre, P., Jenkins, A., Hsu, W., Lee, M., Wong, T. (2010). Alterations in retinal microvascular geometry in young type 1 diabetes. Diabetes Care, 33(6), 1331-1336. [More Information]
  • Davis, T., Ting, R., Best, J., Donoghoe, M., Drury, P., Sullivan, D., Jenkins, A., O'Connell, R., Whiting, M., Glasziou, P., Simes, R., Gebski, V., Keech, A., et al (2010). Effects of fenofibrate on renal function in patients with type 2 diabetes mellitus: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) Study. Diabetologia, 54(2), 280-290. [More Information]
  • Chan, D., Hamilton, S., Rye, K., Chew, G., Jenkins, A., Lambert, G., Watts, G. (2010). Fenofibrate Concomitantly Decreases Serum Proprotein Convertase Subtilisin/Kexin Type 9 and Very-Low-Density Lipoprotein Particle Concentrations in Statin-treated Type 2 Diabetic Patients. Diabetes, Obesity and Metabolism, 12(9), 752-756. [More Information]
  • Nobecourt, E., Tabet, F., Lambert, G., Puranik, R., Bao, B., Yan, L., Davies, M., Brown, B., Jenkins, A., Dusting, G., Barter, P., Rye, K., et al (2010). Nonenzymatic Glycation Impairs the Antiinflammatory Properties of Apolipoprotein A-I. Arteriosclerosis, Thrombosis, and Vascular Biology, 30(4), 766-772. [More Information]
  • Griffin, M., Wilson, L., Mok, Y., Januszewski, A., Wilson, A., Karschimkus, C., Romas, E., Lee, A., Godfrey, T., Wong, M., et al (2010). Thioflavin T fluorescence in human serum: correlations with vascular health and cardiovascular risk factors. Clinical Biochemistry, 43(3), 278-286. [More Information]
  • Valaydon, Z., Lee, P., Dale, G., Januszewski, A., Rowley, K., Nandurkar, H., Karschimkus, C., Best, J., Lyons, T., Jenkins, A. (2009). Increased coated-platelet levels in chronic haemodialysis patients. Nephrology, 14(2), 148-154. [More Information]
  • Kreis, A., Wong, T., Islam, F., Klein, R., Klein, B., Cotch, M., Jenkins, A., Shea, S., Wang, J. (2009). Is nuclear magnetic resonance lipoprotein subclass related to diabetic retinopathy? The Multi-Ethnic Study of Atherosclerosis (MESA). Diabetes and Vascular Disease Research, 6(1), 40-42. [More Information]
  • Cheung, N., Donaghue, K., Liew, G., Rogers, S., Wang, J., Lim, S., Jenkins, A., Hsu, W., Lee, M., Wong, T. (2009). Quantitative assessment of early diabetic retinopathy using fractal analysis. Diabetes Care, 32(1), 106-110. [More Information]
  • Lim, S., Cheung, N., Wang, J., Donaghue, K., Liew, G., Amirul Islam, F., Jenkins, A., Wong, T. (2009). Retinal vascular fractal dimension and risk of early diabetic retinopathy: A prospective study of children and adolescents with type 1 diabetes. Diabetes Care, 32(11), 2081-2083. [More Information]
  • Gallego, P., Craig, M., Duffin, A., Bennetts, B., Jenkins, A., Hofer, S., Lam, A., Donaghue, K. (2008). Association Between p.Leu54Met Polymorphism at the Paraoxonase-1 Gene and Plantar Fascia Thickness in Young Subjects With Type 1 Diabetes. Diabetes Care, 31(8), 1585-1589. [More Information]
  • Januszewski, A., Thomas, M., Karschimkus, C., Chung, J., Rowley, K., Nelson, C., O'Neal, D., Dragicevic, G., Harper, C., Best, J., et al (2008). Longitudinal analysis of low-molecular weight fluorophores in type 1 diabetes mellitus. Journal of Medical Investigation, 55(1/2), 29-36. [More Information]
  • Cheung, N., Rogers, S., Donaghue, K., Jenkins, A., Tikellis, G., Wong, T. (2008). Retinal arteriolar dilation predicts retinopathy in adolescents with type 1 diabetes. Diabetes Care, 31(9), 1842-1846. [More Information]
  • Campbell, D., Neal, B., Chalmers, J., Colman, S., Jenkins, A., Kemp, B., Patel, A., MacMahon, S., Woodward, M. (2007). Low-density lipoprotein particles and risk of intracerebral haemorrhage in subjects with cerebrovascular disease. European Journal of Cardiovascular Prevention and Rehabilitation, 14(3), 413-418. [More Information]
  • Campbell, D., Woodward, M., Chalmers, J., Colman, S., Jenkins, A., Kemp, B., Neal, B., Patel, A., MacMahon, S. (2007). Perindopril-based blood pressure-lowering therapy reduces amino-terminal-pro-B-type natriuretic peptide in subjects with cerebrovascular disease. Journal of Hypertension, 25(3), 699-705. [More Information]
  • Nobecourt, E., Davies, M., Brown, B., Curtiss, L., Bonnet, D., Charlton, F., Januszewski, A., Jenkins, A., Barter, P., Rye, K. (2007). The impact of glycation on apolipoprotein A-I structure and its ability to activate lecithin:cholesterol acyltransferase. Diabetologia, 50(3), 643-653. [More Information]
  • Hofer, S., Bennetts, B., Chan, A., Holloway, B., Karschimkus, C., Jenkins, A., Silink, M., Donaghue, K. (2006). Association between PON 1 polymorphisms, PON activity and diabetes complications. Journal of Diabetes and Its Complications, 20(5), 322-328. [More Information]
  • Campbell, D., Woodward, M., Chalmers, J., Colman, S., Jenkins, A., Kemp, B., Patel, A., MacMahon, S. (2006). Perindopril-based blood pressure-lowering therapy reduces amino-terminal-pro-B-type natriuretic peptide levels in subjects with cerebrovascular disease. European Heart Journal, 27(Suppl 1), 781.
  • Alibrahim, E., Donaghue, K., Rogers, S., Hing, S., Jenkins, A., Chan, A., Wong, T. (2006). Retinal vascular caliber and risk of retinopathy in young patients with type 1 diabetes. Ophthalmology, 113(9), 1499-1503. [More Information]
  • Campbell, D., Woodward, M., Chalmers, J., Colman, S., Jenkins, A., Kemp, B., Neal, B., Patel, A., MacMahon, S. (2006). Soluble vascular cell adhesion molecule 1 and N-terminal pro-B-type natriuretic peptide in predicting ischemic stroke in patients with cerebrovascular disease. JAMA Neurology, 63(1), 60-65. [More Information]
  • Campbell, D., Woodward, M., Chalmers, J., Colman, S., Jenkins, A., Neal, B., Patel, A., MacMahon, S. (2005). Amino-terminal pro-B-type natriuretic peptide (NT-proBNP): a risk factor for most seasons. European Heart Journal, 26(Suppl 1), 257.
  • Woodward, M., Lowe, G., Campbell, D., Colman, S., Rumley, A., Chalmers, J., Neal, B., Patel, A., Jenkins, A., Kemp, B., MacMahon, S. (2005). Associations of Inflammatory and Hemostatic Variables With the Risk of Recurrent Stroke. Stroke: a journal of cerebral circulation, 36(10), 2143-2147. [More Information]
  • Campbell, D., Woodward, M., Chalmers, J., Colman, S., Jenkins, A., Kemp, B., Neal, B., Patel, A., MacMahon, S. (2005). Prediction of Heart Failure by Amino Terminal-pro-B-Type Natriuretic Peptide and C-Reactive Protein in Subjects With Cerebrovascular Disease. Hypertension, 45(1), 69-74.
  • Campbell, D., Woodward, M., Chalmers, J., Colman, S., Jenkins, A., Kemp, B., Neal, B., Patel, A., MacMahon, S. (2005). Prediction of Myocardial Infarction by N-Terminal-Pro-B-Type Natriuretic Peptide, C-Reactive Protein, and Renin in Subjects With Cerebrovascular Disease. Circulation, 112(1), 110-116. [More Information]

Conferences

  • Campbell, D., Woodward, M., Chalmers, J., Colman, S., Jenkins, A., Kemp, B., Neal, B., Patel, A., MacMahon, S. (2008). Can NT-proBNP Monitoring Help Prevent Cardiovascular Disease? 13th World Congress on Heart Disease, Italy: Medimond International Proceedings.

2016

  • Kaidonis, G., Gillies, M., Abhary, S., Liu, E., Essex, R., Chang, J., Pal, B., Sivaprasad, S., Pefkianaki, M., Daniell, M., et al (2016). A single-nucleotide polymorphism in the MicroRNA-146a gene is associated with diabetic nephropathy and sight-threatening diabetic retinopathy in Caucasian patients. Acta Diabetologica, 53(4), 643-650. [More Information]
  • Zhang, Y., Jenkins, A., Basu, A., Stoner, J., Lopes-Virella, M., Klein, R., Lyons, T. (2016). Associations between intensive diabetes therapy and NMR-determined lipoprotein subclass profiles in Type 1 diabetes. Journal of Lipid Research, 57(2), 310-317. [More Information]
  • Joglekar, M., Januszewski, A., Jenkins, A., Hardikar, A. (2016). Circulating microRNA Biomarkers of Diabetic Retinopathy. Diabetes, 65(1), 22-24. [More Information]
  • Ritte, R., Luke, J., Nelson, C., Brown, A., O'Dea, K., Jenkins, A., Best, J., McDermott, R., Daniel, M., Rowley, K. (2016). Clinical outcomes associated with albuminuria in central Australia: a cohort study. BMC Nephrology, 17(1). [More Information]
  • Basu, A., Jenkins, A., Zhang, Y., Stoner, J., Klein, R., Lopes-Virella, M., Garvey, W., Lyons, T. (2016). Data on carotid intima-media thickness and lipoprotein subclasses in type 1 diabetes from the Diabetes Control and Complications Trial and the Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC). Data in Brief, 6, 33-38. [More Information]
  • Tully, P., Baumeister, H., Martin, S., Atlantis, E., Jenkins, A., Januszewski, A., O'Loughlin, P., Taylor, A., Wittert, G. (2016). Elucidating the Biological Mechanisms Linking Depressive Symptoms With Type 2 Diabetes in Men: The Longitudinal Effects of Inflammation, Microvascular Dysfunction, and Testosterone. Psychosomatic Medicine, 78(2), 221-232. [More Information]
  • Bursell, S., Zang, S., Keech, A., Jenkins, A. (2016). Evolving telehealth reimbursement in Australia. Internal Medicine Journal, 46(8), 977-981. [More Information]
  • McAuley, S., Dang, T., Horsburgh, J., Bansal, A., Ward, G., Aroyan, S., Jenkins, A., MacIsaac, R., Shah, R., O'Neal, D. (2016). Feasibility of an Orthogonal Redundant Sensor incorporating Optical plus Redundant Electrochemical Glucose Sensing. Journal of Diabetes Science and Technology, 10(3), 679-688. [More Information]
  • Ogle, G., Kim, H., Middlehurst, A., Silink, M., Jenkins, A. (2016). Financial costs for families of children with Type 1 diabetes in lower-income countries. Diabetic Medicine, 33(6), 820-826. [More Information]
  • Joglekar, M., Trivedi, P., Kay, T., Hawthorne, W., O'Connell, P., Jenkins, A., Hardikar, A., Thomas, H. (2016). Human islet cells are killed by BID-independent mechanisms in response to FAS ligand. Apoptosis, 21(4), 379-389. [More Information]
  • Manski-Nankervis, J., Yates, C., Blackberry, I., Furler, J., Ginnivan, L., Cohen, N., Jenkins, A., Vasanthakumar, S., Gorelik, A., Young, D., et al (2016). Impact of insulin initiation on glycaemic variability and glucose profiles in a primary healthcare Type 2 diabetes cohort: Analysis of continuous glucose monitoring data from the INITIATION study. Diabetic Medicine, 33(6), 803-811. [More Information]
  • McAuley, S., Horsburgh, J., Ward, G., La Gerche, A., Gooley, J., Jenkins, A., MacIsaac, R., O'Neal, D. (2016). Insulin pump basal adjustment for exercise in type 1 diabetes: a randomised crossover study. Diabetologia, 59(8), 1636-1644. [More Information]
  • Kar, P., Plummer, M., Bellomo, R., Jenkins, A., Januszewski, A., Chapman, M., Jones, K., Horowitz, M., Deane, A. (2016). Liberal Glycemic Control in Critically Ill Patients with Type 2 Diabetes: An Exploratory Study. Critical Care Medicine, 44(9), 1695-1703. [More Information]
  • Williams, K., Sullivan, D., Veillard, A., O'Brien, R., George, J., Jenkins, A., Young, S., Ehnholm, C., Duffield, A., Twigg, S., Keech, A. (2016). Low alanine aminotransferase levels and higher number of cardiovascular events in people with Type 2 diabetes: analysis of the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study. Diabetic Medicine, 33(3), 356-364. [More Information]
  • Li, J., Wittert, G., Vincent, A., Atlantis, E., Shi, Z., Appleton, S., Hill, C., Jenkins, A., Januszewski, A., Adams, R. (2016). Muscle grip strength predicts incident type 2 diabetes: Population-based cohort study. Metabolism: Clinical and Experimental, 65(6), 883-892. [More Information]
  • Basu, A., Jenkins, A., Zhang, Y., Stoner, J., Klein, R., Lopes-Virella, M., Garvey, W., Lyons, T., Research Group, T. (2016). Nuclear magnetic resonance-determined lipoprotein subclasses and carotid intima-media thickness in type 1 diabetes. Atherosclerosis, 244, 93-100. [More Information]
  • Luke, J., Schmidt, D., Ritte, R., O'Dea, K., Brown, A., Piers, L., Jenkins, A., Rowley, K. (2016). Nutritional predictors of chronic disease in a Central Australian Aboriginal cohort: A multi-mixture modelling analysis. Nutrition, Metabolism & Cardiovascular Diseases, 26(2), 162-168. [More Information]
  • Luke, J., Ritte, R., O'Dea, K., Brown, A., Piers, L., Jenkins, A., Rowley, K. (2016). Nutritional predictors of successful chronic disease prevention for a community cohort in Central Australia. Public Health Nutrition, 19(13), 2475-2483. [More Information]
  • Williams, K., Sullivan, D., Nicholson, G., George, J., Jenkins, A., Januszewski, A., Gebski, V., Manning, P., Tan, Y., Donoghoe, M., Buizen, L., Twigg, S., Keech, A., et al (2016). Opposite associations between alanine aminotransferase and γ-glutamyl transferase levels and all-cause mortality in type 2 diabetes: Analysis of the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study. Metabolism: Clinical and Experimental, 65(5), 783-793. [More Information]
  • Stern, K., Cho, Y., Benitez-Aguirre, P., Jenkins, A., McGill, M., Mitchell, P., Keech, A., Donaghue, K. (2016). QT interval, corrected for heart rate, is associated with HbA1c concentration and autonomic function in diabetes. Diabetic Medicine, 33(10), 1415-1421. [More Information]
  • Sharifi, A., Varsavsky, A., Ulloa, J., Horsburgh, J., McAuley, S., Krishnamurthy, B., Jenkins, A., Colman, P., Ward, G., MacIsaac, R., et al (2016). Redundancy in Glucose Sensing: Enhanced Accuracy and Reliability of an Electrochemical Redundant Sensor for Continuous Glucose Monitoring. Journal of Diabetes Science and Technology, 10(3), 669-678. [More Information]
  • Noonan, J., Ward, G., Sarossy, M., Man, R., Nguyen, T., Jenkins, A., Dusting, G., Lamoureux, J. (2016). Retinal neuronal and vascular function in type 1 diabetes adults during glycaemic clamps. Clinical and Experimental Pharmacology and Physiology, 43(3), 382-384. [More Information]
  • Januszewski, A., Sutanto, S., McLennan, S., O'Neal, D., Keech, A., Twigg, S., Jenkins, A. (2016). Shorter telomeres in adults with Type 1 diabetes correlate with diabetes duration, but only weakly with vascular function and risk factors. American Journal Of Hematology, 117, 4-11. [More Information]
  • O'Brien, C., Ski, C., Thompson, D., Moore, G., Mancuso, S., Jenkins, A., Ward, G., MacIsaac, R., Loh, M., et al (2016). The Mental Health in Diabetes Service (MINDS) to enhance psychosocial health: study protocol for a randomized controlled trial. Trials, 17(1), 1-10. [More Information]
  • Stitt, A., Curtis, T., Chen, M., Medina, R., McKay, G., Jenkins, A., Gardiner, T., Lyons, T., Hammes, H., Simo, R., et al (2016). The progress in understanding and treatment of diabetic retinopathy. Progress in Retinal and Eye Research, 51, 156-186. [More Information]
  • Traill, C., Januszewski, A., Larkins, R., Keech, A., Jenkins, A. (2016). Time to research Australian female physician-researchers. Internal Medicine Journal, 46(4), 412-419. [More Information]
  • Traill, C., Januszewski, A., Larkins, R., Keech, A., Jenkins, A. (2016). Time to research Australian physician-researchers. Internal Medicine Journal, 46(5), 550-558. [More Information]

2015

  • Hookham, M., Yu, J., Jenkins, A., Hanssen, K., Aston, C., Lyons, T. (2015). [146-POS]: Levels of urinary NGAL and KIM-1 early in pregnancy are indicative of subclinical kidney injury in diabetic women who subsequently developed pre-eclampsia. Pregnancy Hypertension: an international journal of women's cardiovascular health, 5(1), 75-76. [More Information]
  • Farr, R., Januszewski, A., Joglekar, M., Liang, H., McAulley, A., Hewitt, A., Thomas, H., Loudovaris, T., Kay, T., Jenkins, A., Hardikar, A. (2015). A comparative analysis of high-throughput platforms for validation of a circulating microRNA signature in diabetic retinopathy. Scientific Reports, 5, 1-13. [More Information]
  • Ho, M., Benitez-Aguirre, P., Donaghue, K., Mitchell, P., Baur, L., Jenkins, A., Craig, M., Cowell, C., Garnett, S. (2015). Arterial elasticity in obese adolescents with clinical features of insulin resistance. Diabetes and Vascular Disease Research, 12(1), 62-69. [More Information]
  • Jenkins, A., Joglekar, M., Hardikar, A., Keech, A., O'Neal, D., Januszewski, A. (2015). Biomarkers in Diabetic Retinopathy. The Review of Diabetic Studies, 12(1-2), 159-195. [More Information]
  • Sasongko, M., Wong, T., Jenkins, A., Nguyen, T., Shaw, J., Wang, J. (2015). Circulating markers of inflammation and endothelial function, and their relationship to diabetic retinopathy. Diabetic Medicine, 32(5), 686-691. [More Information]
  • Kaidonis, G., Burdon, K., Gillies, M., Abhary, S., Essex, R., Chang, J., Pal, B., Pefkianaki, M., Daniell, M., Lake, S., Jenkins, A., et al (2015). Common Sequence Variation in the VEGFC Gene Is Associated with Diabetic Retinopathy and Diabetic Macular Edema. Ophthalmology, 122(9), 1828-1836. [More Information]
  • Pipingas, A., Sinclair, A., Croft, K., Januszewski, A., Jenkins, A., Mori, T., Cockerell, R., Grima, N., Stough, C., Scholey, A., et al (2015). Fish oil and multivitamin supplementation reduces oxidative stress but not inflammation in healthy older adults: A randomised controlled trial. Journal of Functional Foods, 19, 949-957. [More Information]
  • Burdon, K., Fogarty, R., Shen, W., Abhary, S., Kaidonis, G., Appukuttan, B., Hewitt, A., Sharma, S., Daniell, M., Essex, R., Jenkins, A., Gillies, M., et al (2015). Genome-wide association study for sight-threatening diabetic retinopathy reveals association with genetic variation near the GRB2 gene. Diabetologia, 58(10), 2288-2297. [More Information]
  • Xu, S., Alexander, K., Bryant, W., Cohen, N., Craig, M., Forbes, M., Fulcher, G., Greenaway, T., Harrison, N., Holmes-Walker, J., Jenkins, A., et al (2015). Healthcare professional requirements for the care of adult diabetes patients managed with insulin pumps in Australia. Internal Medicine Journal, 45(1), 86-93. [More Information]
  • Chin, J., Fulcher, J., Jenkins, A., Keech, A. (2015). Is it Time to Repair a Fairly Fast SAAB Convertible? Testing an Evidence-based Mnemonic for the Secondary Prevention of Cardiovascular Disease. Heart, Lung and Circulation, 24(5), 480-487. [More Information]
  • Martin, S., Vincent, A., Taylor, A., Atlantis, E., Jenkins, A., Januszewski, A., O'Loughlin, P., Wittert, G. (2015). Lower Urinary Tract Symptoms, Depression, Anxiety and Systemic Inflammatory Factors in Men: A Population-Based Cohort Study. PloS One, 10(10), 1-18. [More Information]
  • Sabeti, F., Nolan, C., James, A., Jenkins, A., Maddess, T. (2015). Multifocal Pupillography Identifies Changes in Visual Sensitivity According to Severity of Diabetic Retinopathy in Type 2 Diabetes. Investigative Ophthalmology & Visual Science, 56(8), 4504-4513. [More Information]
  • Hardikar, A., Satoor, S., Karandikar, M., Joglekar, M., Puranik, A., Wong, W., Kumar, S., Limaye, A., Bhat, D., Januszewski, A., Keech, A., Jenkins, A., et al (2015). Multigenerational Undernutrition Increases Susceptibility to Obesity and Diabetes that Is Not Reversed after Dietary Recuperation. Cell Metabolism, 22(2), 312-319. [More Information]
  • Ong, K., Januszewski, A., O'Connell, R., Buizen, L., Jenkins, A., Xu, A., Sullivan, D., Barter, P., Scott, R., Taskinen, M., Rye, K., Keech, A. (2015). Relationship of fibroblast growth factor 21 with baseline and new on-study microvascular disease in the Fenofibrate Intervention and Event Lowering in Diabetes study. Diabetologia, 59(8), 2035-2044. [More Information]
  • Herrmann, M., Sullivan, D., Veillard, A., McCorquodale, T., Straub, I., Scott, R., Laakso, M., Topliss, D., Jenkins, A., Blankenberg, S., Keech, A., et al (2015). Serum 25-Hydroxy Vitamin D: A Predictor of Macrovascular and Microvascular Complications in Patients With Type 2 Diabetes. Diabetes Care, 38(3), 521-528. [More Information]
  • Benitez-Aguirre, P., Craig, M., Cass, H., Sugden, C., Jenkins, A., Wang, J., Cusumano, J., Hodgson, L., Lee, K., Wong, T., Donaghue, K. (2015). Sex differences in retinal microvasculature through puberty in type 1 diabetes: are girls at greater risk of diabetic microvascular complications? Investigative Ophthalmology & Visual Science, 56(1), 571-577. [More Information]
  • Tully, P., Baumeister, H., Bengel, J., Jenkins, A., Januszewski, A., Martin, S., Wittert, G. (2015). The longitudinal association between inflammation and incident depressive symptoms in men: The effects of hs-CRP are independent of abdominal obesity and metabolic disturbances. Physiology and Behavior, 139, 328-335. [More Information]
  • Ong, K., Januszewski, A., O'Connell, R., Jenkins, A., Xu, A., Sullivan, D., Barter, P., Hung, W., Scott, R., Taskinen, M., Keech, A., Rye, K. (2015). The relationship of fibroblast growth factor 21 with cardiovascular outcome events in the Fenofibrate Intervention and Event Lowering in Diabetes study. Diabetologia, 58(3), 464-473. [More Information]
  • Jenkins, A. (2015). The world I want - A world with less diabetes. Medical Journal of Australia, 202(2), 108-109. [More Information]
  • Basu, A., Yu, J., Jenkins, A., Nankervis, A., Hanssen, K., Henriksen, T., Lorentzen, B., Garg, S., Menard, K., Hammad, S., et al (2015). Trace elements as predictors of preeclampsia in type 1 diabetic pregnancy. Nutrition Research, 35(5), 421-430. [More Information]

2014

  • Jenkins, A., Fu, D., Azar, M., Stoner, J., Kaufman, D., Zhang, S., Klein, R., Lopes-Virella, M., Ma, J., Lyons, T. (2014). Clinical correlates of serum pigment epithelium-derived factor in type 2 diabetes patients. Journal of Diabetes and Its Complications, 28, 353-359. [More Information]
  • McBride, J., Jenkins, A., Liu, X., Zhang, B., Lee, K., Berry, W., Janknecht, R., Griffin, C., Aston, C., Lyons, T., et al (2014). Elevated Circulation Levels of an Antiangiogenic SERPIN in Patients with Diabetic Microvascular Complications Impair Wound Healing through Suppression of Wnt Signaling. Journal of Investigative Dermatology, 134, 1725-1734. [More Information]
  • Noonan, J., Dusting, G., Nguyen, T., Jenkins, A., Man, R., Best, W., Dias, D., Jayasinghe, N., Roessner, U., Lamoureux, E. (2014). Flicker Light-Induced Retinal Vasodilation is Unaffected by Inhibition of Epoxyeicosatrienoic Acids and Prostaglandins in Humans. Investigative Ophthalmology & Visual Science, 55(10), 7007-7013. [More Information]
  • Waldman, B., Jenkins, A., Davis, T., Taskinen, M., Scott, R., O'Connell, R., Gebski, V., Ng, M., Keech, A. (2014). HDL-C and HDL-C/ApoA-I Predict Long-Term Progression of Glycemia in Established Type 2 Diabetes. Diabetes Care, 37(8), 2351-2358. [More Information]
  • Ding, L., Cheng, R., Hu, Y., Takahashi, Y., Jenkins, A., Keech, A., Humphries, K., Gu, X., Elliott, M., Xia, X., et al (2014). Peroxisome Proliferator–Activated Receptor α Protects Capillary Pericytes in the Retina. The American Journal of Pathology, 184(10), 2709-2720. [More Information]
  • Januszewski, A., Mason, N., Karschimkus, C., Rowley, K., Best, J., O'Neal, D., Jenkins, A. (2014). Plasma semicarbazide-sensitive amine oxidase activity in type 1 diabetes is related to vascular and renal function but not to glycaemia. Diabetes and Vascular Disease Research, 11(4), 262-269. [More Information]
  • Basu, A., Jenkins, A., Stoner, J., Thorpe, S., Klein, R., Lopes-Virella, M., Garvey, W., Lyons, T. (2014). Plasma total homocysteine and carotid intima-media thickness in type 1 diabetes: A prospective study. Atherosclerosis, 236(1), 188-195. [More Information]
  • Hendrieckx, C., Halliday, J., Bowden, J., Colman, P., Cohen, N., Jenkins, A., Speight, J. (2014). Severe hypoglycaemia and its association with psychological well-being in Australian adults with type 1 diabetes attending specialist tertiary clinics. Diabetes Research and Clinical Practice, 103(3), 430-436. [More Information]
  • Jenkins, A. (2014). Sometimes you have to give a man a fish. Medical Journal of Australia, 200(2), 122-123. [More Information]
  • Vethakkan, S., Walters, J., Gooley, J., Boston, R., Kay, T., Goodman, D., Jenkins, A., Ward, G. (2014). The incretin response after successful islet transplantation. Transplantation, 97(2), e9-e11. [More Information]

2013

  • Naser, N., Januszewski, A., Brown, B., Jenkins, A., Hill, M., Murphy, T. (2013). Advanced glycation end products acutely impair ca(2+) signaling in bovine aortic endothelial cells. Frontiers in Physiology, 4, 1-14. [More Information]
  • Noonan, J., Jenkins, A., Ma, J., Keech, A., Wang, J., Lamoureux, E. (2013). An Update on the Molecular Actions of Fenofibrate and Its Clinical Effects on Diabetic Retinopathy and Other Microvascular End Points in Patients With Diabetes. Diabetes, 62(12), 3968-3975. [More Information]
  • Brown, B., Nobecourt, E., Zeng, J., Jenkins, A., Rye, K., Davies, M. (2013). Apolipoprotein A-I glycation by Glucose and Reactive Aldehydes Alters Phospholipid Affinity but Not Cholesterol Export from Lipid-Laden Macrophages. PloS One, 8(5), 1-9. [More Information]
  • Azar, M., Lyons, T., Alaupovic, P., Stoner, J., Quiroga, C., Kaufman, D., Lopes-Virella, M., Klein, R., Jenkins, A. (2013). Apolipoprotein-defined and NMR lipoprotein subclasses in the Veterans Affairs Diabetes Trial. Journal of Diabetes and Its Complications, 27(6), 627-632. [More Information]
  • Jenkins, A., Yu, J., Alaupovic, P., Basu, A., Klein, R., Lopes-Virella, M., Baker, N., Hunt, K., Lackland, D., Garvey, W., et al (2013). Apolipoprotein-defined lipoproteins and apolipoproteins: Associations with abnormal albuminuria in type 1 diabetes in the diabetes control and complications trial/epidemiology of diabetes interventions and complications cohort. Journal of Diabetes and Its Complications, 27(5), 447-453. [More Information]
  • Jenkins, A., O'Neal, D. (2013). Dyslipidaemia in diabetes: a common problem worth treating to target. Endocrinology Today: peer reviewed updates for medical practitioners, 2(2), 24-29.
  • O'Neal, D., Adhya, S., Jenkins, A., Ward, G., Welsh, J., Voskanyan, G. (2013). Feasibility of adjacent insulin infusion and continuous glucose monitoring via the Medtronic Combo-Set. Journal of Diabetes Science and Technology, 7(2), 381-388. [More Information]
  • Seller, D., Scibilia, R., Rodda, C., Jenkins, A. (2013). Growth in insulin pump use in Australian children with Type 1 Diabetes, and subsequent impact on a diabetes camp program. Infusystems Asia, 8(3), 25-30.
  • Samaras, K., Viardot, A., Botelho, N., Jenkins, A., Lord, R. (2013). Immune cell-mediated inflammation and the early improvements in glucose metabolism after gastric banding surgery. Diabetologia, 56(12), 2564-2572.
  • Hunt, K., Baker, N., Cleary, P., Backlund, J., Lyons, T., Jenkins, A., Virella, G., Lopes-Virella, M. (2013). Oxidized LDL and AGE-LDL in circulating immune complexes strongly predict progression of carotid artery IMT in type 1 diabetes. Atherosclerosis, 231(2), 315-322. [More Information]
  • Alexander, K., Bryant, W., Cohen, N., Craig, M., Forbes, M., Fulcher, G., Greenaway, T., Harrison, N., Holmes-Walker, J., Howard, G., Jenkins, A., et al (2013). Provision of Quality Care for Adults with Type 1 Diabetes Requiring Insulin Pump Therapy (IIPT). Infusystems Asia, 8(1), 1-6.
  • Rasmussen, B., Hendrieckx, C., Clarke, B., Botti, M., Dunning, T., Jenkins, A., Speight, J. (2013). Psychosocial issues of women with type 1 diabetes transitioning to motherhood: a structured literature review. BMC Pregnancy and Childbirth, 13, 2-10. [More Information]
  • Samaras, K., Viardot, A., Lee, P., Jenkins, A., Botelho, N., Bakopanos, A., Lord, R., Hayward, C. (2013). Reduced arterial stiffness after weight loss in obese type 2 diabetes and impaired glucose tolerance: the role of immune cell activation and insulin resistance. Diabetes and Vascular Disease Research, 10(1), 40-48. [More Information]
  • Campbell, D., Somaratne, J., Jenkins, A., Prior, D., Yii, M., Kenny, J., Newcomb, A., Kelly, D., Black, M. (2013). Reduced microvascular density in non-ischemic myocardium of patients with recent non-ST-segment-elevation myocardial infarction. International Journal of Cardiology, 167(3), 1027-1237. [More Information]
  • Luke, J., Brown, A., Daniel, M., O'Dea, K., Best, J., Jenkins, A., Wang, Z., McDermott, R., Wang, Z., Rowley, K. (2013). Response to the Letter by Kawada et al. regarding the manuscript entitled "The metabolic syndrome and CVD outcomes for a central Australian cohort". Diabetes Research and Clinical Practice, 102(2), e22-e23. [More Information]
  • Du, M., Basu, A., Fu, D., Wu, M., Centola, M., Jenkins, A., Hanssen, K., Garg, S., Hammad, S., Scardo, J., et al (2013). Serum inflammatory markers and preeclampsia in type 1 diabetes: a prospective study. Diabetes Care, 36(7), 2054-2061. [More Information]
  • Bursell, S., Jenkins, A., Brazionisb, L., Rowley, K., Brown, A. (2013). Telehealth in Australia: an evolution in health care services. Medical Journal of Australia, 199(1), 23-24. [More Information]
  • Luke, J., Brown, A., Daniell, M., O'Dea, K., Best, J., Jenkins, A., Wang, Z., McDermott, R., Wang, Z., Rowley, K. (2013). The metabolic syndrome and CVD outcomes for a central Australian cohort. Diabetes Research and Clinical Practice, 100(3), e70-e73. [More Information]
  • Chen, Y., Hu, Y., Lin, M., Jenkins, A., Keech, A., Mott, R., Lyons, T., Ma, J. (2013). Therapeutic Effects of PPARα Agonists on Diabetic Retinopathy in Type 1 Diabetes Models. Diabetes, 62(1), 261-272. [More Information]
  • Jenkins, A., O'Neal, D. (2013). What do insulin pumps offer in diabetes care? Endocrinology Today: peer reviewed updates for medical practitioners, 2(4), 27-30.

2012

  • Ting, R., Keech, A., Drury, P., Donoghoe, M., Hedley, J., Jenkins, A., Davis, T., Lehto, S., Celermajer, D., Simes, R., Rajamani, K., et al (2012). Benefits and Safety of Long-Term Fenofibrate Therapy in People With Type 2 Diabetes and Renal Impairment - The FIELD Study. Diabetes Care, 35(2), 218-225. [More Information]
  • Campbell, D., Somaratne, J., Jenkins, A., Prior, D., Yii, M., Kenny, J., Newcomb, A., Schalkwijk, C., Black, M., Kelly, D. (2012). Diastolic dysfunction of aging is independent of myocardial structure but associated with plasma advanced glycation end-product levels. PloS One, 7(11), 1-14. [More Information]
  • Lopes-Virella, M., Jenkins, A., Baker, N., Virella, G., Hunt, K., Lyons, T., et al (2012). High concentrations of AGE-LDL and oxidized LDL in circulating immune complexes are associated with progression of retinopathy in type 1 diabetes. Diabetes Care, 35(6), 1333-1340. [More Information]
  • Ong, K., Rye, K., O'Connell, R., Jenkins, A., Brown, C., Xu, A., Sullivan, D., Barter, P., Keech, A. (2012). Long-Term Fenofibrate Therapy Increases Fibroblast Growth Factor 21 and Retinol-Binding Protein 4 in Subjects with Type 2 Diabetes. Journal of Clinical Endocrinology and Metabolism, 97(12), 4701-4708. [More Information]
  • Januszewski, A., Sachithanandan, N., Karschimkus, C., o'neal, D., Yeung, C., Alkatib, N., Jenkins, A. (2012). Non-invasive measures of tissue autofluorescence are increased in Type 1 diabetes complications and correlate with a non-invasive measure of vascular dysfunction. Diabetic Medicine, 29(6), 726-733. [More Information]
  • Vethakkan, S., Walters, J., Gooley, J., Boston, R., Kay, T., Goodman, D., Jenkins, A., Ward, G. (2012). Normalized NEFA dynamics during an OGTT after islet transplantation. Transplantation, 94(7), e49-e51. [More Information]
  • Sasongko, M., Wong, T., Nguyen, T., Shaw, J., Jenkins, A., Wang, J. (2012). Novel versus traditional risk markers for diabetic retinopathy. Diabetologia, 55(3), 666-670. [More Information]
  • Benitez-Aguirre, P., Craig, M., Jenkins, A., Gallego, P., Cusumano, J., Duffin, A., Hing, S., Donaghue, K. (2012). Plantar Fascia Thickness is Longitudinally Associated with Retinopathy and Renal Dysfunction: A Prospective Study from Adolescence to Adulthood. Journal of Diabetes Science and Technology, 6(2), 348-355. [More Information]
  • Januszewski, A., Karschimkus, C., Davis, K., O'Neal, D., Ward, G., Jenkins, A. (2012). Plasma 1,5 anhydroglucitol levels, a measure of short-term glycaemia: Assay assessment and lower levels in diabetic vs. non-diabetic subjects. Diabetes Research and Clinical Practice, 95(1), e17-e19. [More Information]
  • Basu, A., Alaupovic, P., Wu, M., Jenkins, A., Yu, Y., Nankervis, A., Hanssen, K., Scholz, H., Henriksen, T., Lorentzen, B., et al (2012). Plasma lipoproteins and preeclampsia in women with type 1 diabetes: a prospective study. Journal of Clinical Endocrinology and Metabolism, 97(5), 1752-1762. [More Information]
  • Sasongko, M., Wong, T., Donaghue, K., Cheung, N., Jenkins, A., Benitez-Aguirre, P., Wang, J. (2012). Retinal Arteriolar Tortuosity is Associated With Retinopathy and Early Kidney Dysfunction in Type 1 Diabetes. American Journal of Ophthalmology, 153(1), 176-183. [More Information]
  • Benitez-Aguirre, P., Sasongko, M., Craig, M., Jenkins, A., Cusumano, J., Cheung, N., Wong, T., Donaghue, K. (2012). Retinal vascular geometry predicts incident renal dysfunction in young people with type 1 diabetes. Diabetes Care, 35(3), 599-604. [More Information]
  • Sasongko, M., Wong, T., Nguyen, T., Kawasaki, R., Jenkins, A., Shaw, J., Robinson, C., Wang, J. (2012). Serum Apolipoproteins are Associated With Systemic and Retinal Microvascular Function in People With Diabetes. Diabetes, 61(7), 1785-1792. [More Information]
  • Bursell, S., Brazionis, L., Jenkins, A. (2012). Telemedicine and ocular health in diabetes mellitus. Clinical & Experimental Optometry, 95(3), 311-327. [More Information]

2011

  • Davis, T., Ting, R., Best, J., Donoghoe, M., Drury, P., Sullivan, D., Jenkins, A., O'Connell, R., Whiting, M., Glasziou, P., Simes, R., Gebski, V., Keech, A., et al (2011). Effects of fenofibrate on renal function in patients with type 2 diabetes mellitus: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) Study. Diabetologia, 54(2), 280-290. [More Information]
  • Tabet, F., Lambert, G., Torres, L., Hou, L., Sotirchos, I., Touyz, R., Jenkins, A., Barter, P., Rye, K. (2011). Lipid-Free Apolipoprotein A-I and Discoidal Reconstituted High-Density Lipoproteins Differentially Inhibit Glucose-Induced Oxidative Stress in Human Macrophages. Arteriosclerosis, Thrombosis, and Vascular Biology, 31(5), 1192-1200. [More Information]
  • Benitez-Aguirre, P., Craig, M., Sasongko, M., Jenkins, A., Wong, T., Wang, J., Cheung, N., Donaghue, K. (2011). Retinal Vascular Geometry Predicts Incident Retinopathy in Young People With Type 1 Diabetes. Diabetes Care, 34(7), 1622-1627. [More Information]
  • Sasongko, M., Wong, T., Nguyen, T., Kawasaki, R., Jenkins, A., Shaw, J., Wang, J. (2011). Serum Apolipoprotein AI and B Are Stronger Biomarkers of Diabetic Retinopathy Than Traditional Lipids. Diabetes Care, 34(2), 474-479. [More Information]

2010

  • Sasongko, M., Wang, J., Donaghue, K., Cheung, N., Benitez-Aguirre, P., Jenkins, A., Hsu, W., Lee, M., Wong, T. (2010). Alterations in retinal microvascular geometry in young type 1 diabetes. Diabetes Care, 33(6), 1331-1336. [More Information]
  • Davis, T., Ting, R., Best, J., Donoghoe, M., Drury, P., Sullivan, D., Jenkins, A., O'Connell, R., Whiting, M., Glasziou, P., Simes, R., Gebski, V., Keech, A., et al (2010). Effects of fenofibrate on renal function in patients with type 2 diabetes mellitus: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) Study. Diabetologia, 54(2), 280-290. [More Information]
  • Chan, D., Hamilton, S., Rye, K., Chew, G., Jenkins, A., Lambert, G., Watts, G. (2010). Fenofibrate Concomitantly Decreases Serum Proprotein Convertase Subtilisin/Kexin Type 9 and Very-Low-Density Lipoprotein Particle Concentrations in Statin-treated Type 2 Diabetic Patients. Diabetes, Obesity and Metabolism, 12(9), 752-756. [More Information]
  • Nobecourt, E., Tabet, F., Lambert, G., Puranik, R., Bao, B., Yan, L., Davies, M., Brown, B., Jenkins, A., Dusting, G., Barter, P., Rye, K., et al (2010). Nonenzymatic Glycation Impairs the Antiinflammatory Properties of Apolipoprotein A-I. Arteriosclerosis, Thrombosis, and Vascular Biology, 30(4), 766-772. [More Information]
  • Griffin, M., Wilson, L., Mok, Y., Januszewski, A., Wilson, A., Karschimkus, C., Romas, E., Lee, A., Godfrey, T., Wong, M., et al (2010). Thioflavin T fluorescence in human serum: correlations with vascular health and cardiovascular risk factors. Clinical Biochemistry, 43(3), 278-286. [More Information]

2009

  • Valaydon, Z., Lee, P., Dale, G., Januszewski, A., Rowley, K., Nandurkar, H., Karschimkus, C., Best, J., Lyons, T., Jenkins, A. (2009). Increased coated-platelet levels in chronic haemodialysis patients. Nephrology, 14(2), 148-154. [More Information]
  • Kreis, A., Wong, T., Islam, F., Klein, R., Klein, B., Cotch, M., Jenkins, A., Shea, S., Wang, J. (2009). Is nuclear magnetic resonance lipoprotein subclass related to diabetic retinopathy? The Multi-Ethnic Study of Atherosclerosis (MESA). Diabetes and Vascular Disease Research, 6(1), 40-42. [More Information]
  • Cheung, N., Donaghue, K., Liew, G., Rogers, S., Wang, J., Lim, S., Jenkins, A., Hsu, W., Lee, M., Wong, T. (2009). Quantitative assessment of early diabetic retinopathy using fractal analysis. Diabetes Care, 32(1), 106-110. [More Information]
  • Lim, S., Cheung, N., Wang, J., Donaghue, K., Liew, G., Amirul Islam, F., Jenkins, A., Wong, T. (2009). Retinal vascular fractal dimension and risk of early diabetic retinopathy: A prospective study of children and adolescents with type 1 diabetes. Diabetes Care, 32(11), 2081-2083. [More Information]

2008

  • Gallego, P., Craig, M., Duffin, A., Bennetts, B., Jenkins, A., Hofer, S., Lam, A., Donaghue, K. (2008). Association Between p.Leu54Met Polymorphism at the Paraoxonase-1 Gene and Plantar Fascia Thickness in Young Subjects With Type 1 Diabetes. Diabetes Care, 31(8), 1585-1589. [More Information]
  • Campbell, D., Woodward, M., Chalmers, J., Colman, S., Jenkins, A., Kemp, B., Neal, B., Patel, A., MacMahon, S. (2008). Can NT-proBNP Monitoring Help Prevent Cardiovascular Disease? 13th World Congress on Heart Disease, Italy: Medimond International Proceedings.
  • Januszewski, A., Thomas, M., Karschimkus, C., Chung, J., Rowley, K., Nelson, C., O'Neal, D., Dragicevic, G., Harper, C., Best, J., et al (2008). Longitudinal analysis of low-molecular weight fluorophores in type 1 diabetes mellitus. Journal of Medical Investigation, 55(1/2), 29-36. [More Information]
  • Cheung, N., Rogers, S., Donaghue, K., Jenkins, A., Tikellis, G., Wong, T. (2008). Retinal arteriolar dilation predicts retinopathy in adolescents with type 1 diabetes. Diabetes Care, 31(9), 1842-1846. [More Information]

2007

  • Campbell, D., Neal, B., Chalmers, J., Colman, S., Jenkins, A., Kemp, B., Patel, A., MacMahon, S., Woodward, M. (2007). Low-density lipoprotein particles and risk of intracerebral haemorrhage in subjects with cerebrovascular disease. European Journal of Cardiovascular Prevention and Rehabilitation, 14(3), 413-418. [More Information]
  • Campbell, D., Woodward, M., Chalmers, J., Colman, S., Jenkins, A., Kemp, B., Neal, B., Patel, A., MacMahon, S. (2007). Perindopril-based blood pressure-lowering therapy reduces amino-terminal-pro-B-type natriuretic peptide in subjects with cerebrovascular disease. Journal of Hypertension, 25(3), 699-705. [More Information]
  • Nobecourt, E., Davies, M., Brown, B., Curtiss, L., Bonnet, D., Charlton, F., Januszewski, A., Jenkins, A., Barter, P., Rye, K. (2007). The impact of glycation on apolipoprotein A-I structure and its ability to activate lecithin:cholesterol acyltransferase. Diabetologia, 50(3), 643-653. [More Information]

2006

  • Hofer, S., Bennetts, B., Chan, A., Holloway, B., Karschimkus, C., Jenkins, A., Silink, M., Donaghue, K. (2006). Association between PON 1 polymorphisms, PON activity and diabetes complications. Journal of Diabetes and Its Complications, 20(5), 322-328. [More Information]
  • Campbell, D., Woodward, M., Chalmers, J., Colman, S., Jenkins, A., Kemp, B., Patel, A., MacMahon, S. (2006). Perindopril-based blood pressure-lowering therapy reduces amino-terminal-pro-B-type natriuretic peptide levels in subjects with cerebrovascular disease. European Heart Journal, 27(Suppl 1), 781.
  • Alibrahim, E., Donaghue, K., Rogers, S., Hing, S., Jenkins, A., Chan, A., Wong, T. (2006). Retinal vascular caliber and risk of retinopathy in young patients with type 1 diabetes. Ophthalmology, 113(9), 1499-1503. [More Information]
  • Campbell, D., Woodward, M., Chalmers, J., Colman, S., Jenkins, A., Kemp, B., Neal, B., Patel, A., MacMahon, S. (2006). Soluble vascular cell adhesion molecule 1 and N-terminal pro-B-type natriuretic peptide in predicting ischemic stroke in patients with cerebrovascular disease. JAMA Neurology, 63(1), 60-65. [More Information]

2005

  • Campbell, D., Woodward, M., Chalmers, J., Colman, S., Jenkins, A., Neal, B., Patel, A., MacMahon, S. (2005). Amino-terminal pro-B-type natriuretic peptide (NT-proBNP): a risk factor for most seasons. European Heart Journal, 26(Suppl 1), 257.
  • Woodward, M., Lowe, G., Campbell, D., Colman, S., Rumley, A., Chalmers, J., Neal, B., Patel, A., Jenkins, A., Kemp, B., MacMahon, S. (2005). Associations of Inflammatory and Hemostatic Variables With the Risk of Recurrent Stroke. Stroke: a journal of cerebral circulation, 36(10), 2143-2147. [More Information]
  • Campbell, D., Woodward, M., Chalmers, J., Colman, S., Jenkins, A., Kemp, B., Neal, B., Patel, A., MacMahon, S. (2005). Prediction of Heart Failure by Amino Terminal-pro-B-Type Natriuretic Peptide and C-Reactive Protein in Subjects With Cerebrovascular Disease. Hypertension, 45(1), 69-74.
  • Campbell, D., Woodward, M., Chalmers, J., Colman, S., Jenkins, A., Kemp, B., Neal, B., Patel, A., MacMahon, S. (2005). Prediction of Myocardial Infarction by N-Terminal-Pro-B-Type Natriuretic Peptide, C-Reactive Protein, and Renin in Subjects With Cerebrovascular Disease. Circulation, 112(1), 110-116. [More Information]

2003

  • Jenkins, A., Breen, R., Lindsay, R., Brew, A. (2003). Reshaping Teaching In Higher Education: Linking Teaching With Research. UK: RoutledgeFalmer imprint of Taylor & Francis.

To update your profile click here. For support on your academic profile contact .